Mirror Therapy Tested to Help Hand Recovery After Acute Stroke
Tests mirror therapy with usual physiotherapy in people recovering from acute stroke.
Plain-language title generated from the registry record
Registry title: Mirror Therapy for Hand Function Recovery in Acute Stroke
Key facts
- Where
- Malakand, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 55 years old?
Source: NCT07204067, who can take part
Where in Pakistan
- Riphah international University Malakand CampusMalakand, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Riphah International University
- Trial code
- NCT07204067
- Record updated
- 2 October 2025
- Original description
Randomized controlled trial to determine whether mirror therapy (MT), added to conventional physiotherapy, improves upper-limb motor recovery, hand function, spasticity, and range of motion (ROM) in acute stroke compared with conventional physiotherapy alone. Outcomes include ARAT, Motor Assessment Scale, Modified Ashworth Scale, and goniometric ROM.Read full original descriptionShow less
Effectiveness of Mirror Therapy in Improving Motor Recovery and Hand Function in Patients With Acute Stroke A Randomized Controlled Trial
Randomized controlled trial to determine whether mirror therapy (MT), added to conventional physiotherapy, improves upper-limb motor recovery, hand function, spasticity, and range of motion (ROM) in acute stroke compared with conventional physiotherapy alone. Outcomes include ARAT, Motor Assessment Scale, Modified Ashworth Scale, and goniometric ROM.
Inclusion: Age 40-55 years; Acute ischemic or hemorrhagic stroke within the last 1 month; Unilateral hemiparesis/hemiplegia; Medically stable and cleared for rehabilitation; Able to follow verbal instructions; MMSE ≥ 24; Provides written informed consent.
Exclusion: Concurrent enrollment in other interventional trials; Recurrent stroke or bilateral involvement; Severe cognitive impairment (MMSE < 24); Other neurological disorders (e.g., Parkinson's, MS); Orthopedic conditions affecting upper limb/trunk; Uncontrolled cardio-respiratory disease limiting exercise; Visual field deficits, unilateral neglect, or severe aphasia interfering with MT; Severe spasticity (MAS ≥ 3) in affected limb; Inability/refusal to consent.